DaVitri: Semi-Automated Vitrificacion Clinical Study

Launched by OVERTURE LIFE · Nov 2, 2022

Keywords

ClinConnect Summary

The DaVitri clinical study is looking at a new device called DaVitri, which helps prepare human samples for a process called vitrification. Vitrification is a way to freeze eggs, embryos, or other cells quickly and safely, which is important for people facing fertility issues. The goal of this study is to see if using the DaVitri device is just as effective as the current methods used for this process.

To participate in the trial, you need to be a female donor between the ages of 18 and 35 and meet certain health criteria, including being free from certain infectious and genetic diseases. You won't be eligible if you have a low or high body mass index (BMI), have had issues with implantation in the past, or have specific menstrual cycle problems. If you join the study, you can expect to work closely with healthcare professionals who will guide you through the process and help ensure your safety and comfort. This study is currently recruiting participants, so if you think you might qualify, it could be a great opportunity to contribute to important research in fertility treatments.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Donors will be selected according to the clinic's usual inclusion criteria in terms of infectious diseases, genetic diseases, karyotype, etc.
• Exclusion Criteria:
• • BMI\<18.5 or BMI \>25
• • Implantation failure
• • Abnormal ovulation cycle
• • Endometrial thickness \> 7mm